Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib

Internal Medicine

Volumn 48, Issue 16, 2009, Pages 1433-1435

  Tsuzuki, Motohiro ^a   Inaguma, Youko ^a   Handa, Kousuke ^a   Hasegawa, Akio ^a   Yamamoto, Yukiya ^a   Watanabe, Masato ^a   Mizuta, Syuichi ^a   Maruyama, Fumio ^a   Okamoto, Masataka ^a   Emi, Nobuhiko ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic myeloid leukemia; Imatinib; Pregnancy

Indexed keywords

ALPHA INTERFERON; HYDROXYUREA; IMATINIB;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CONGENITAL MALFORMATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETAL WELL BEING; FETUS OUTCOME; GESTATIONAL AGE; HUMAN; INFANT; LABOR INDUCTION; LEUKEMIA REMISSION; MALE; PREGNANCY DISORDER; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; TREATMENT DURATION;

FEMALE; HUMANS; INFANT, NEWBORN; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; PIPERAZINES; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PYRIMIDINES; REMISSION INDUCTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349485264     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2084     Document Type: Article

References (13)

1. Druker BJ, Guilhot F, O'Brien SG, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355: 2408-2417, 2006.
2. Hensley ML, Ford JM. Imatinib treatment: specific issues related to safety, fertility, and pregnancy. Semin Hematol 40: 21-25, 2003.
3. Ali R, Ozkalemkas F, Ozkocaman V, et al. Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregnancy: a case report and review of the literature. Jpn J Clin Oncol 34: 215-217, 2004.
4. Heartin E, Walkinshaw S, Clark RE. Successful outcome of pregnancy in chronic myelogenous leukemia treated with imatinib. Leuk Lymphoma 45: 1307-1308, 2004.
5. AlKindi S, Dennison D, Pathare A. Imatinib in pregnancy. Eur J Haematol 74: 535-537, 2005.
6. Ali R, Ozakalemkas F, Ozcelik T, et al. Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML) Outcome of discontinuation of imatinib therapy after achieving a molecular remission. Leuk Res 29: 971-973, 2005.
7. Ault P, Kantarjian H, O'Brien S, et al. Pregnancy among patients with chronic myeloid leukemia treated with imatinib. J Clin Oncol 24: 1204-1208, 2006.
8. Pye SM, Cortes J, Ault P, et al. The effects of imatinib on pregnancy outcome. Blood 111: 5505-5508, 2008.
9. Russell MA, Carpenter MW, Akhtar MS, Lagattuta TF, Egorin MJ. Imatinib mesylate and metabolite concentrations in maternal blood, umbilical cord blood, placenta and breast milk. J Perinatol 27: 241-243, 2007.
10. Gambacorti-Passerini CB, Tomaghi L, Marangon E, et al. Imatinib concentrations in human milk. Blood 109: 1790, 2007.
11. Ali R, Qzkalemkas F, Kimya Y, et al. Imatinib use during pregnancy and breast feeding: a case report and review literature. Arch Gynecol Obstet 2009 (in press).
12. Glivec clinical monograph. Basel, Switzerland: Novartis Pharma AG; 2004.
13. Rousselot P, Huguet F, Rea D, et al. Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years. Blood 109: 58-60, 2007.